Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2020 2
2021 1
2022 1
2024 3
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy.
Scheiner B, Kang B, Balcar L, Radu IP, Reiter FP, Adžić G, Guo J, Gao X, Yuan X, Cheng L, Gorgulho J, Schultheiss M, Peeters F, Hucke F, Ben Khaled N, Piseddu I, Philipp A, Sinner F, D'Alessio A, Pomej K, Saborowski A, Bathon M, Schwacha-Eipper B, Zarka V, Lampichler K, Nishida N, Lee PC, Krall A, Saeed A, Himmelsbach V, Tesini G, Huang YH, Vivaldi C, Masi G, Vogel A, Schulze K, Trauner M, Djanani A, Stauber R, Kudo M, Parikh ND, Dufour JF, Prejac J, Geier A, Bengsch B, von Felden J, Venerito M, Weinmann A, Peck-Radosavljevic M, Finkelmeier F, Dekervel J, Ji F, Wang HW, Rimassa L, Pinato DJ, Bouattour M, Chon HJ, Pinter M. Scheiner B, et al. Among authors: tesini g. Hepatology. 2025 Jun 1;81(6):1714-1727. doi: 10.1097/HEP.0000000000001163. Epub 2024 Nov 21. Hepatology. 2025. PMID: 39643944
Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real-world results from a multicenter and multinational study.
Rimini M, Fornaro L, Prinzi FL, Rizzato MD, Saborowski A, Antonuzzo L, Rossari F, Satake T, Peeters F, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, Salani F, De Rosa A, Lavacchi D, Camera S, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Corallo S, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Vitiello F, Himmelsbach V, Landriscina M, Djaballah SA, Tesini G, Masi G, Vogel A, Lonardi S, Rimassa L, Casadei-Gardini A. Rimini M, et al. Among authors: tesini g. Int J Cancer. 2025 Sep 15;157(6):1246-1259. doi: 10.1002/ijc.35481. Epub 2025 May 19. Int J Cancer. 2025. PMID: 40387725
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index.
Persano M, Rimini M, Salani F, Prinzi FL, Nichetti F, Saborowski A, Antonuzzo L, Passeri L, Satake T, Peeters F, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Corallo S, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pirrone C, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, Fornaro L, De Rosa A, Lanzetta I, Balsano R, Lavacchi D, Camera S, Ikeda M, Dekervel J, Niger M, Tesini G, Tonini G, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Ferrara M, Himmelsbach V, Landriscina M, Djaballah SA, Masi G, Vogel A, Lonardi S, Rimassa L, Casadei-Gardini A. Persano M, et al. Among authors: tesini g. Liver Int. 2025 Jul;45(7):e70181. doi: 10.1111/liv.70181. Liver Int. 2025. PMID: 40525496
Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapy.
Vitiello F, Vivaldi C, Rizzato MD, Saborowski A, Antonuzzo L, Rossari F, Salani F, Kim JW, Rapposelli IG, Tamburini E, Rimini M, Prinzi FL, Satake T, Peeters F, Pressiani T, Lucchetti J, Abidoye O, Gallio C, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pastorino A, Castet F, Yoo C, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Parisi A, Diana A, Couto N, Chan SL, Garajova I, Roque R, Ikeda M, Niger M, Tonini G, Himmelsbach V, Landriscina M, Masi G, Vogel A, Lonardi S, Fornaro L, Rimassa L, Casadei-Gardini A, Adeva J, Spinelli GP, Personeni N, Rodriguez MG, Leo S, Alvim CM, Farinea G, Genovesi V, De Rosa A, Lavacchi D, Camera S, Dekervel J, Balsano R, Kang M, Tesini G, Esposito L, Boccancino A, Ahcene Djaballah S, Bekaii-Saab T. Vitiello F, et al. Among authors: tesini g. Oncology. 2025 Aug 14:1-26. doi: 10.1159/000546856. Online ahead of print. Oncology. 2025. PMID: 40815107
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real-life worldwide population.
Prinzi FL, Salani F, Camera S, Rizzato MD, Saborowski A, Antonuzzo L, Rossari F, Satake T, Peeters F, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Gallio C, Tamberi S, Finkelmeier F, Giordano G, Chiara P, Chon HJ, Braconi C, Qaisar A, Pastorino A, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Couto N, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Polito MG, Di Giacomo E, Farinea G, Bartalini L, Grelli G, De Rosa A, Lavacchi D, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Kang M, Tesini G, Boccaccino A, Himmelsbach V, Landriscina M, Djaballah SA, Bekaii-Saab T, Fornaro L, Masi G, Vogel A, Lonardi S, Rimini M, Rimassa L, Casadei-Gardini A. Prinzi FL, et al. Among authors: tesini g. Int J Cancer. 2025 Nov 15;157(10):2092-2102. doi: 10.1002/ijc.70009. Epub 2025 Jul 11. Int J Cancer. 2025. PMID: 40641448 Free PMC article.
Review of immune therapy in HCC: Where are we now and what is the future?
Zanuso V, Pirozzi A, Tesini G, Rimassa L. Zanuso V, et al. Among authors: tesini g. Clin Liver Dis (Hoboken). 2024 Jun 14;23(1):e0149. doi: 10.1097/CLD.0000000000000149. eCollection 2024 Jan-Jun. Clin Liver Dis (Hoboken). 2024. PMID: 38881724 Free PMC article. No abstract available.
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study.
Giannella M, Rinaldi M, Tesini G, Gallo M, Cipriani V, Vatamanu O, Campoli C, Toschi A, Ferraro G, Horna CS, Bartoletti M, Ambretti S, Violante F, Viale P, Curti S. Giannella M, et al. Among authors: tesini g. Infection. 2022 Oct;50(5):1243-1253. doi: 10.1007/s15010-022-01801-2. Epub 2022 Apr 29. Infection. 2022. PMID: 35488112 Free PMC article.
15 results